Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Finland |
---|---|
Lista | First North Finland |
Sektor | Hälsovård |
Industri | Bioteknik |
TR-1: Standard form for notification of major holdings
NOTIFICATION OF
MAJOR HOLDINGS
(to
be sent to the
relevant issuer
and
to the FCA in
Microsoft Word
format
if possible) i1a. Identity of Faron Pharmaceuticals
the issuer or the Ltd
underlying issuer
of existing
shares
to which voting
rights are
attached
ii:
1b. Please
indicate if the
issuer is
a non-UK issuer
(please mark with
an
"X" if
appropriate)
Non-UK issuer X
2. Reason for the
notification
(please mark the
appropriate box
or
boxes with an
"X")
An acquisition or X
disposal of
voting
rights
An acquisition or X
disposal of
financial
instruments
An event changing
the breakdown of
voting rights
Other (please X
specify) iii:
Change
due the Share
Offering
3. Details of
person subject to
the
notification
obligation iv
Name Timo Syrjälä
City and country Lausanne, Switzerland
of registered
office (if
applicable)
4. Full name of
shareholder(s)
(if
different from
3.) v
Name 20.6.2024
City and country 20.6.2024
of registered
office (if
applicable)
5. Date on which 20.6.2024
the threshold was
crossed or
reached vi:
6. Date on which 20.6.2024
issuer notified
(DD/MM/YYYY):
7. Total
positions of
person(s)
subject to the
notification
obligation
% of voting % of voting Total of both Total
rights rights in % (8.A + number of
attached to through 8.B) voting
shares financial rights
(total instruments held in
of 8. A) (total of issuer
8.B 1 + 8.B (8.A +
2) 8.B) vii
Resulting 15,32% 16,024,023
situation on the
date on
which threshold
was crossed or
reached
Position of 18,48% 13,308,001
previous
notification
(ifapplicable)
8. Notified
details of the
resulting
situation on
the date on
which the
threshold was
crossed or
reached viii
A: Voting
rights
attached to
shares
Class/type of Number of % of
shares voting voting
rights ix rights
ISIN code (if
possible)
Direct Indirect Direct Indirect(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
FI4000153309 5,526,277 10,497,796 5,28% 10,03%SUBTOTAL 8. A 16,024,023 15,32%
B 1: Financial
Instruments
according to
DTR5.3.1R (1)
(a)
Type of Expiration Exercise/ Number of % of
financial date x Conversion voting voting
instrument Period xi rights rights
that may
be
acquired
if the
instrument
isexercised/c
onverted.SUBTOTAL
8. B 1B 2: Financial
Instruments
with similar
economic
effect
according to
DTR5.3.1R (1)
(b)
Type of Expiration Exercise/ Physical Number of voting % of
financial date x Conversion or cash rights voting
instrument Period xi rights
Settlement
xiiSUBTOTAL
8.B.29. Information in
relation to the
person subject to
the notification
obligation (please
mark theapplicable box
with an "X")
Person subject to
the notification
obligation is not
controlled by any
natural person or
legal entity and
does not control
any other
undertaking(s)
holding directly
or indirectly an
interest in the
(underlying)
issuer xiii
Full chain of X
controlled
undertakings
through which the
voting rights
and/or the
financial
instruments are
effectively held
starting with the
ultimate
controlling
natural person or
legal entity
(please add
additional rows as
necessary) xiv
Name xv % of voting rights if it equals or is % of voting Total of
higher than the notifiable threshold rights both if it
through equals or
financial is higher
instruments than the
if it notifiable
equals or threshold
is higher
than the
notifiable
threshold
Timo Syrjälä 5,28% 5,28%
(Direct)
Acme Investments 10,03% 10,03%
SPF Sarl
(Indirect)10. In case of
proxy voting,
please identify:
Name of the proxy
holder
The number and %
of voting rights
held
The date until
which the voting
rights will be
held11. Additional
information xvi
Faron Share
Offering 20.6.2024+-------------------+---------------------+
|Place of completion|Lausanne, Switzerland|
+-------------------+---------------------+
|Date of completion |20.6.2024 |
+-------------------+---------------------+